← Leaderboards
Alessandro Doria
Joslin Diabetes Center
$38,225,772
Attributed
$55,759,904
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $25.5M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,759,904 · 14
By mechanism
UC4$31,562,202 · 1
R01$21,034,971 · 6
P30$2,604,589 · 4
R21$261,742 · 1
R34$189,720 · 1
R03$106,680 · 1
Top collaborators
- S Michael Mauer8 shared
- Rohit N. Kulkarni4 shared
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusPreventClinical ResearchResearch PersonnelLinkGeneticBaseGenotypeNon-Insulin-Dependent Diabetes MellitusPharmaceutical PreparationsInsightResponseSamplingCardiovascular DiseasesGenetic MarkersServicesGenesAtherosclerosisMolecularClinical TrialsComplications Of Diabetes MellitusFundingInsulin-Dependent Diabetes MellitusPathway Interactions
Grant awards (63)
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes$811,054
R01 · FY2025 · HL · contact PI
Molecular Phenotyping and Genotyping Core$284,345
P30 · FY2025 · DK · contact PI
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes$778,620
R01 · FY2024 · HL · contact PI
Molecular Phenotyping and Genotyping Core$284,345
P30 · FY2024 · DK · contact PI
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes$787,613
R01 · FY2023 · HL · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$341,580
R01 · FY2023 · DK · contact PI
Molecular Phenotyping and Genotyping Core$243,368
P30 · FY2023 · DK · contact PI
Early myocardial remodeling and progressive kidney function decline in type 1 diabetes$821,720
R01 · FY2022 · HL · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$330,098
R01 · FY2022 · DK · contact PI
Molecular Phenotyping and Genotyping Core$242,655
P30 · FY2022 · DK · contact PI
A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes$375,469
R01 · FY2021 · DK · contact PI
Genotype-dependent cardiovascular and anti-inflammatory effects of fenofibrate$134,992
R21 · FY2021 · HL · contact PI
Genotype-dependent cardiovascular and anti-inflammatory effects of fenofibrate$126,750
R21 · FY2020 · HL · contact PI
Metabolic pathways of increased cardiovascular risk in type 2 diabetes$755,711
R01 · FY2019 · HL · contact PI
Metabolic pathways of increased cardiovascular risk in type 2 diabetes$772,947
R01 · FY2018 · HL · contact PI
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D$250,000
UC4 · FY2018 · DK · contact PI
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D$7,000,000
UC4 · FY2017 · DK · contact PI
Metabolic pathways of increased cardiovascular risk in type 2 diabetes$800,585
R01 · FY2017 · HL · contact PI
Metabolic pathways of increased cardiovascular risk in type 2 diabetes$851,576
R01 · FY2016 · HL · contact PI
Enrichment Program$74,686
P30 · FY2016 · DK · contact PI
Enrichment Program$74,685
P30 · FY2016 · DK · contact PI
Enrichment Program$73,777
P30 · FY2015 · DK · contact PI
Enrichment Program$73,776
P30 · FY2015 · DK · contact PI
Genetic modifiers of the effect of intensive glycemic control on CVD risk$594,702
R01 · FY2014 · HL · contact PI
Search for new MODY genes and molecular studies of their function in beta cells$403,297
R01 · FY2014 · DK · contact PI
Enrichment Program$74,686
P30 · FY2014 · DK · contact PI
Enrichment Program$74,685
P30 · FY2014 · DK · contact PI
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D$24,312,202
UC4 · FY2013 · DK · contact PI
Genetic modifiers of the effect of intensive glycemic control on CVD risk$586,087
R01 · FY2013 · HL · contact PI
Search for new MODY genes and molecular studies of their function in beta cells$432,248
R01 · FY2013 · DK · contact PI
Enrichment Program$72,757
P30 · FY2013 · DK · contact PI
Enrichment Program$72,757
P30 · FY2013 · DK · contact PI
Genetic modifiers of the effect of intensive glycemic control on CVD risk$1,266,639
R01 · FY2012 · HL · contact PI
Search for new MODY genes and molecular studies of their function in beta cells$631,134
R01 · FY2012 · DK · contact PI
Genetics of Coronary Artery Disease in Type 2 Diabetes$589,147
R01 · FY2012 · HL · contact PI
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D$189,720
R34 · FY2012 · DK · contact PI
Enrichment Program$19,838
P30 · FY2012 · DK · contact PI
Genetic modifiers of the effect of intensive glycemic control on CVD risk$1,338,840
R01 · FY2011 · HL · contact PI
Search for new MODY genes and molecular studies of their function in beta cells$695,837
R01 · FY2011 · DK · contact PI
Genetics of Coronary Artery Disease in Type 2 Diabetes$603,471
R01 · FY2011 · HL · contact PI
GENETICS CORE$186,781
P30 · FY2011 · DK · contact PI
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D$106,680
R03 · FY2011 · DK · contact PI
Genetics of Coronary Artery Disease in Type 2 Diabetes$631,455
R01 · FY2010 · HL · contact PI
GENETICS CORE$211,309
P30 · FY2010 · DK · contact PI
Genetics of Coronary Artery Disease in Type 2 Diabetes$613,928
R01 · FY2009 · HL · contact PI
GENETICS CORE$193,000
P30 · FY2009 · DK · contact PI
Genetics of Coronary Artery Disease in Type 2 Diabetes$640,107
R01 · FY2008 · HL · contact PI
GENETICS CORE$188,053
P30 · FY2008 · DK · contact PI
Variability in Adipokine Genes and Atherosclerosis$524,173
R01 · FY2007 · HL · contact PI
GENETICS CORE$159,086
P30 · FY2007 · DK · contact PI
Variability in Adipokine Genes and Atherosclerosis$525,731
R01 · FY2006 · HL · contact PI
Search for Insulin Resistance Genes in Early Onest T2DM$314,929
R01 · FY2006 · DK · contact PI
Variability in Adipokine Genes and Atherosclerosis$569,153
R01 · FY2005 · HL
Search for Insulin Resistance Genes in Early Onest T2DM$314,501
R01 · FY2005 · DK
Variability in Adipokine Genes and Atherosclerosis$545,435
R01 · FY2004 · HL
Search for Insulin Resistance Genes in Early Onest T2DM$346,848
R01 · FY2004 · DK
Variability in Adipokine Genes and Atherosclerosis$557,498
R01 · FY2003 · HL
Search for Insulin Resistance Genes in Early Onset T2DM$338,738
R01 · FY2003 · DK
SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM$172,200
R01 · FY2002 · DK
Core--Genetics$0
P30 · FY2002 · DK
SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM$172,200
R01 · FY2001 · DK
SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM$172,200
R01 · FY2000 · DK
SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM$27,500
R01 · FY2000 · DK